SMTL ID : 5ci9.1

Crystal structure of human Tob in complex with inhibitor fragment 6

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

2 x 549: 1-(propan-2-yl)-1H-benzimidazole-5-carboxylic acid(Non-covalent)

549.1: 4 residues within 4Å: Chain A: P.47, P.50, F.98, D.116 1 PLIP interactions: 1 interactions with chain A pi-Stacking: A:F.98 549.2: 2 residues within 4Å: Chain A: H.60, K.64 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:H.60

1 x NA: SODIUM ION(Non-functional Binders)

NA.3: 3 residues within 4Å: Chain A: P.22, R.24, R.25 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.24, A:R.25, A:R.25

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bai, Y. et al., Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach. Protein Cell (2015)

Release Date

2015-11-18

Peptides

Protein Tob1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein Tob1